科美诊断: 科美诊断技术股份有限公司2025年第一次临时股东会决议公告

Core Points - The company held its first extraordinary general meeting of shareholders on September 5, 2025, with no rejected proposals [1] - The meeting was attended by 57 ordinary shareholders, representing 127,097,347 voting rights, which accounts for 32.2097% of the total voting rights of the company [1] - All non-cumulative voting proposals were approved with a significant majority, with the highest approval rate being 99.6214% for one of the proposals [2][3] Meeting Details - The meeting was convened by the board of directors and chaired by Mr. Li Lin, utilizing a combination of on-site and online voting methods [1] - The voting procedures complied with the Company Law and the company's articles of association [1] - Legal representatives confirmed that the meeting's convening and voting procedures were in accordance with relevant laws and regulations [4] Voting Results - The voting results showed overwhelming support for the proposals, with the highest number of votes in favor reaching 126,616,255, representing 99.6214% [2][3] - The dissenting votes were minimal, with the highest opposition being 416,960, which is only 0.3280% of the total votes [2] - The proposals included the election of several directors, all of which were passed with significant majorities [3][4]